Iovance Biotherapeutics Dividends
| IOVA Stock | USD 2.53 0.17 7.20% |
As of February 8, 2026, Dividends Paid is expected to decline to about 1.1 M. In addition to that, Dividend Yield is expected to decline to 0.10. Iovance Biotherapeutics' past performance could be the main factor of why investors trade Iovance Biotherapeutics stock today. Investors should clearly understand every aspect of the Iovance Biotherapeutics dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest Iovance Biotherapeutics' dividend schedule and payout information. Iovance Biotherapeutics dividends can also provide a clue to the current valuation of Iovance Biotherapeutics.
| Last Reported | Projected for Next Year | ||
| Dividends Paid | 1.1 M | 1.1 M | |
| Dividend Yield | 0.12 | 0.10 | |
| Dividend Payout Ratio | (0.84) | (0.88) | |
| Dividend Paid And Capex Coverage Ratio | (28.70) | (30.13) |
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in Iovance Biotherapeutics must own a stock before its ex-dividend date to receive its next dividend.
Iovance Biotherapeutics Dividends Paid Over Time
Today, most investors in Iovance Biotherapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Iovance Biotherapeutics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's dividends paid growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Iovance Biotherapeutics dividends paid as a starting point in their analysis.
The total amount of dividends that a company has paid out to its shareholders over a specific period. Dividends Paid |
| Timeline |
Iovance Biotherapeutics Historical Dividend Yield Growth
A solid dividend growth pattern of Iovance Biotherapeutics could indicate future dividend growth is likely, which can signal long-term profitability for Iovance Biotherapeutics. When investors calculate the dividend yield growth rate, they can use any interval of time they wish. They may also calculate the dividend yield growth rate using the least-squares method or simply take an annualized figure over a given time period. Dividend Yield is Iovance Biotherapeutics dividend as a percentage of Iovance Biotherapeutics stock price. Iovance Biotherapeutics dividend yield is a measure of Iovance Biotherapeutics stock productivity, which can be interpreted as interest rate earned on an Iovance Biotherapeutics investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share. Dividend Yield |
| Timeline |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Iovance Biotherapeutics. Market participants price Iovance higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Iovance Biotherapeutics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (1.19) | Revenue Per Share | Quarterly Revenue Growth 0.152 | Return On Assets | Return On Equity |
Understanding Iovance Biotherapeutics requires distinguishing between market price and book value, where the latter reflects Iovance's accounting equity. The concept of intrinsic value - what Iovance Biotherapeutics' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Iovance Biotherapeutics' price substantially above or below its fundamental value.
Please note, there is a significant difference between Iovance Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Iovance Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Iovance Biotherapeutics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.